<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04539184</url>
  </required_header>
  <id_info>
    <org_study_id>JS-CT-2020-08</org_study_id>
    <nct_id>NCT04539184</nct_id>
  </id_info>
  <brief_title>The Effectiveness and Cost-effectiveness of Motion Style Acupuncture Treatment (MSAT) for Acute Neck Pain: A Multi-center Randomized Controlled Trial</brief_title>
  <official_title>The Effectiveness and Cost-effectiveness of Motion Style Acupuncture Treatment (MSAT) for Acute Neck Pain: A Multi-center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jaseng Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jaseng Medical Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the comparative effectiveness and safety of Motion Style&#xD;
      Acupuncture Treatment (MSAT) therapy for acute neck pain compared to acupuncture.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, randomized, controlled, comparative effectiveness clinical trial for&#xD;
      acute neck pain. Motion style acupuncture requires a part of the patient's body to move&#xD;
      passively or actively while acupuncture needles are retained.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Actual">November 18, 2021</completion_date>
  <primary_completion_date type="Actual">November 18, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale(VAS) on movement</measure>
    <time_frame>Change from baseline VAS at 3 weeks</time_frame>
    <description>Minimum 0, Maximum 100. Higher values represent a worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) on movement</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Minimum 0, Maximum 100. Higher values represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) at rest</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Minimum 0, Maximum 100. Higher values represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) on movement</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Minimum 0, Maximum 10. Higher values represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) at rest</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Minimum 0, Maximum 10. Higher values represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vernon-Mior Neck Disability Index (NDI)</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Functional disability questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Northwick Park Neck Pain Questionnaire (NPQ)</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Functional disability questionnaire and Pain questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC)</measure>
    <time_frame>Week 3, 8</time_frame>
    <description>Global, patient-reported outcome, Minimum 1, Maximum 7, Higher values represent a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of flexion</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of flexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of extension</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of extension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of Rt rotation</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of Right rotation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of Lt rotation</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of Left rotation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of Lt lateroflexion</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of Left lateroflexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of movement (ROM) of Rt lateroflexion</measure>
    <time_frame>Baseline(Week 1), Week 2, 3, 8</time_frame>
    <description>Range of movement of Right lateroflexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L</measure>
    <time_frame>Baseline(Week 1), 3, 8</time_frame>
    <description>Health-related quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-item Short-Form Health Survey (SF-12)</measure>
    <time_frame>Baseline(Week 1), 3, 8</time_frame>
    <description>Health-related quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol Visual Analogue Scale (EQ-VAS)</measure>
    <time_frame>Baseline(Week 1), 3, 8</time_frame>
    <description>Health-related quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)</time_frame>
    <description>Safety outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug Consumption</measure>
    <time_frame>Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)</time_frame>
    <description>Drug type and dose of prescribe for medicine or rescue medicine, and type and frequency of other treatments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Acute Neck Pain</condition>
  <arm_group>
    <arm_group_label>Motion Style Acupuncture treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Motion Style Acupuncture treatment (2-3 times/week, 2 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acupuncture treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acupuncture treatment (2-3 times/week, 2 weeks)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Motion Style Acupuncture Treatment (MSAT)</intervention_name>
    <description>MSAT required a part of the patient's body to move passively or actively while acupuncture needles are retained.</description>
    <arm_group_label>Motion Style Acupuncture treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>General acupuncture</description>
    <arm_group_label>Acupuncture treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neck pain onset or worsen within one month&#xD;
&#xD;
          -  VAS of neck pain on movement or at rest of 5 or higher&#xD;
&#xD;
          -  Age between 19 and 70 years old&#xD;
&#xD;
          -  Participants who wrote a informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants who diagnosed with the serious disease that can cause pain (e.g.&#xD;
             Migration of cancer reaching to spine, fracture of spine, dislocation of spine)&#xD;
&#xD;
          -  Progressive neurologic deficits or severe neurologic deficits&#xD;
&#xD;
          -  Participants who diagnosed with a soft tissue disease that can cause pain (Cancer,&#xD;
             fibromyalgia, RA, or goat)&#xD;
&#xD;
          -  Chronic disease (e.g. Cardiovascular disease, kidney disease, dementia, diabetic&#xD;
             neuropathy, or epilepsy)&#xD;
&#xD;
          -  Participants taking steroids, immunosuppressants, or psychotropic medication&#xD;
&#xD;
          -  Participants who could be inadequate or unsafe at acupuncture (e.g. Hemorrhagic&#xD;
             disease, severe diabetes or taking anticoagulant drug)&#xD;
&#xD;
          -  Participants who took NSAIDs or acupuncture within 3 days&#xD;
&#xD;
          -  Participants who had undergone cervical surgery within 3 months&#xD;
&#xD;
          -  Participants who had a traffic accident within a month&#xD;
&#xD;
          -  Pregnant or women who planned to conceive&#xD;
&#xD;
          -  Participants who had participated in other clinical trial within 1 month, or have plan&#xD;
             for participation in other trial within 6 months from enrollment&#xD;
&#xD;
          -  Participants who can not write informed consent&#xD;
&#xD;
          -  Participants who is difficult to participate in the trial according to investigator's&#xD;
             decision&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In-Hyuk Ha, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jaseng Medical Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jaseng Hospital of Korean Medicine</name>
      <address>
        <city>Seoul</city>
        <state>Gangnam-Gu</state>
        <zip>135-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bucheon Jaseng Hospital of Korean Medicine</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi Province</state>
        <zip>14598</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haeundae Jaseng Hospital of Korean Medicine</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daejeon Jaseng Hospital of Korean Medicine</name>
      <address>
        <city>Daejeon</city>
        <zip>35262</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jaseng Medical Foundation</investigator_affiliation>
    <investigator_full_name>In-Hyuk Ha, KMD</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

